GOLDMAN SACHS GROUP INC - MEI PHARMA INC ownership

MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 112 filers reported holding MEI PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MEI PHARMA INC
ValueSharesWeighting
Q4 2022$5,148
-14.2%
21,132
+41.9%
0.00%
Q3 2022$6,000
-91.3%
14,887
-87.0%
0.00%
Q2 2022$69,000
-55.2%
114,122
-55.4%
0.00%
Q1 2022$154,000
-75.4%
255,594
+8.9%
0.00%
Q4 2021$627,000
-21.7%
234,776
-19.1%
0.00%
Q3 2021$801,000
-40.1%
290,201
-38.2%
0.00%
Q2 2021$1,338,000
-52.6%
469,246
-42.9%
0.00%
-100.0%
Q1 2021$2,821,000
+142.8%
822,225
+86.7%
0.00%
Q4 2020$1,162,000
-11.7%
440,404
+4.4%
0.00%
Q3 2020$1,316,000
-5.8%
421,936
+24.7%
0.00%
Q2 2020$1,397,000
+721.8%
338,252
+221.3%
0.00%
Q1 2020$170,000
+24.1%
105,265
+90.3%
0.00%
Q4 2019$137,000
+101.5%
55,325
+36.8%
0.00%
Q3 2019$68,000
-75.3%
40,433
-63.3%
0.00%
Q2 2019$275,000
-60.0%
110,084
-50.9%
0.00%
Q1 2019$688,000
+189.1%
224,147
+270.5%
0.00%
Q2 2018$238,000
+561.1%
60,493
+248.3%
0.00%
Q1 2018$36,000
-37.9%
17,367
-37.1%
0.00%
Q4 2017$58,000
-64.0%
27,629
-58.9%
0.00%
Q2 2017$161,000
+22.9%
67,209
-16.6%
0.00%
Q1 2017$131,000
+162.0%
80,570
+131.7%
0.00%
Q4 2016$50,000
-45.1%
34,777
-32.4%
0.00%
Q3 2016$91,000
+193.5%
51,429
+119.8%
0.00%
Q2 2016$31,000
+10.7%
23,399
+4.6%
0.00%
Q1 2016$28,000
-37.8%
22,364
-20.7%
0.00%
Q4 2015$45,000
-66.7%
28,209
-67.2%
0.00%
Q3 2015$135,000
-61.4%
85,923
-57.9%
0.00%
Q2 2015$350,000
-9.6%
204,323
-5.3%
0.00%
Q1 2015$387,000
+90.6%
215,789
+354.1%
0.00%
Q4 2014$203,000
-52.6%
47,515
-23.4%
0.00%
Q3 2014$428,000
+205.7%
62,045
+180.5%
0.00%
Q2 2014$140,000
-58.7%
22,119
-27.4%
0.00%
Q1 2014$339,000
+28.4%
30,449
-7.8%
0.00%
Q4 2013$264,00033,0150.00%
Other shareholders

There were no reported owners of MEI PHARMA INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of MEI PHARMA INC shareholders